CE
CE
NYSE · Chemicals

Celanese Corp

$44.38
-1.03 (-2.27%)
Financial Highlights (FY 2026)
Revenue
9.94B
Net Income
-1,213,850,814
Gross Margin
20.4%
Profit Margin
-12.2%
Rev Growth
-0.5%
D/E Ratio
3.11
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.4% 20.4% 40.9% 40.9%
Operating Margin -8.2% -7.4% 18.8% 18.9%
Profit Margin -12.2% -11.6% 15.6% 12.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.94B 9.99B 2.08B 1.79B
Gross Profit 2.03B 2.04B 852.49M 731.91M
Operating Income -819,403,985 -740,797,173 392.60M 337.78M
Net Income -1,213,850,814 -1,097,404,050 324.52M 228.88M
Gross Margin 20.4% 20.4% 40.9% 40.9%
Operating Margin -8.2% -7.4% 18.8% 18.9%
Profit Margin -12.2% -11.6% 15.6% 12.8%
Rev Growth -0.5% -0.5% +18.6% -1.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.96B 1.96B 1.63B 1.70B
Total Equity 630.24M 630.24M 2.56B 3.02B
D/E Ratio 3.11 3.11 0.64 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -648,084,014 -618,462,896 538.54M 453.84M
Free Cash Flow 161.90M 161.57M